Patent · US Active

Treatment for diabetes in patients inappropriate for metformin therapy

US10034877B2 · kind B2 · utility

11Cited by

154References

17Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Klaus Dugi · Dresden, DE
Eva Ulrike GRAEFE-MODY · Ingelheim am Rhein, DE
Ruth HARPER · Rowstock, GB
Hans-Juergen WOERLE · Munich, DE

Key dates

Filing date	Oct 6, 2016
Grant date	Jul 31, 2018
Priority date	—
Expiry date	Oct 6, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication against metformin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.